欧洲药品管理局已启动对丹麦制药商灵北公司生产的抗抑郁和抗焦虑药物黛力新的审查，此前有报告称该药存在“严重的神经和精神副作用”。
The European Medicines Agency has started a review of depression and anxiety medicine Deanxit, made by Danish drugmaker H Lundbeck , after reports of "serious neurological and psychiatric side effects". Here are some details:
以下是部分细节：欧洲药品管理局药物警戒风险评估委员会周五表示，相关报告涉及运动障碍以及记忆和思维问题的病例。
该委员会补充说，在某些病例中，症状在停止治疗后仍持续存在。
灵北公司未立即回应置评请求。
EMA's Pharmacovigilance Risk Assessment Committee said on Friday the reports relate to cases involving movement disorders, and memory and thinking problems The PRAC added that in some cases, symptoms persisted after stopping the treatment H Lundbeck did not immediately respond to a request for comment